Update in IO Neoadjuvant (Preoperative) Trials
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology discusses Update in IO Neoadjuvant (Preoperative) Trialsat the Kidney Cancer Association Inte...
Author: kidneycancer
Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts
New targets in rcc:nktr
Cristina Surez MD PhD Hospital Universitari Vall dHebron-Vall dHebron Institute of Oncology discusses NEW TARGETS IN RCC:NKTR at the Kidney Cancer Association International Symposium 2019 in Dubro...
Author: kidneycancer
Added: 04/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 2, 2019 Category: Cancer & Oncology Source Type: podcasts
Targeting RCC Metabolism: Glutaminase Inhibition
Brian Shuch, MD Associate Professor of Urology<br />Director, UCLA Kidney Cancer Program Alvin & CarrieMeinhardt Endowed Chair in Kidney Cancer Research discusses Targeting RCC Metabolism: Glutaminase I...
Author: superboy
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
TIL products from Renal Cell Carcinomas are tumor-specific but poor cytokine producers
Monika Wolkers, PhD m.wolkers@sanquin.nl discusses TIL products from Renal Cell Carcinomas are tumor-specific but poor cytokine producers at the Kidney Cancer Association International Symposium 2019 ...
Author: superboy
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
New targets in rcc
Bernadett Szabados of Barts Cancer Institute discusses NEW TARGETS IN RCC at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia<br />
Author: superboy
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
Novel epigenetic targeting approaches
W. Kimryn Rathmell, MD, PhD<br />of Vanderbilt Ingram Cancer Center discusses Novel epigenetic targeting approaches at the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia
Author: superboy
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
HIF-2aa new target in metastatic RCC
Laurence Albiges, Gustave Roussy <br />Villejuif, France discusses HIF-2aa new target in metastatic RCCat the Kidney Cancer Association International Symposium 2019 in Dubrovnik, Croatia<br />
Author: superboy
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
Randomised phase 2 study of sapanisertib (TAK228/MLN0128) TAK-117 versus everolimus in patients with VEGF-targeted therapy-refractory metastatic clear cell renal cell carcinoma
Toni K. Choueiri MD of Dana Farber discusses Randomised phase 2 study of sapanisertib (TAK228/MLN0128) TAK-117 versus everolimus in patients with VEGF-targeted therapy-refractory metastatic clear c...
Author: superboy
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
Learning curves in 500 robot-assisted partial nephrectomies: the bed-side assistant counts
Philip Zeuschner, MD of Universitt des Saarlandes, Saarbrcken (UKS) discusses Learning curves in 500 robot-assisted partial nephrectomies: the bed-side assistant counts at the Kidney Cancer Associat...
Author: kidneycancer
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
A First-in-Human Phase 1/2 Trial of the Oral HIF-2a Inhibitor PT2977 in Patients with Advanced RCC
Toni K. Choueiri, MD of Dana-Farber Cancer Institute, Boston, MA discusses A First-in-Human Phase 1/2 Trial of the Oral HIF-2a Inhibitor PT2977 in Patients with Advanced RCCat the Kidney Cancer Assoc...
Author: kidneycancer
Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Small renal masses non surgical management
Prof. Alessandro VOLPE University of Eastern Piedmont Maggiore della Carit Hospital, Novara, Italy discusses SMALL RENAL MASSES NON SURGICAL MANAGEMENT at the Kidney Cancer Association International ...
Author: kidneycancer
Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Stereotactic Ablative Body RadioTherapy in Kidney Cancer
Stereotactic Ablative Body RadioTherapy <br />in Kidney Cancer Ben Vanneste, MD, PhD<br />Radiation-Oncologist, MAASTRO Clinic, The Netherlands discusses Stereotactic Ablative Body RadioTherapy in Kidney Can...
Author: kidneycancer
Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Genomic and Transcriptomic Biomarkers of IO Response in RCC
Dr Kevin Litchfield Kevin.litchfield@crick.ac.uk Twitter: @kevlitchfield discusses Genomic and Transcriptomic Biomarkers of IO Response in RCC at the Kidney Cancer International Symposium 2019 in Dubr...
Author: kidneycancer
Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Martin Gore 1951 - 2019
James Larkin of the The Royal Marsden NHS Foundation Trust pays tribute to his friend and legendary oncologist Martin Gore at the Kidney Cancer International Symposium 2019 in Dubrovnik, Croatia
Author: kidneycancer
Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts
First line clear cell RCC: All change please.
Thomas Powles Director of Barts Cancer Center. Professor of Urology Cancer, Barts Cancer Institute discusses firist line clear cell RCC: All change at the Kidney Cancer International Symposium 2019 i...
Author: kidneycancer
Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts